News

SKAN Research Trust Earns Key Government Approvals in India

SKAN Research Trust Earns Key Government Approvals in India

SKAN Research Trust Receives Significant Government Approvals

SKAN Research Trust has recently achieved two major recognitions that highlight its commitment to advancing medical research. These recognitions are from the Government of India, designating SKAN as a Research Association for Scientific Research and recognizing it as a Scientific and Industrial Research Organization (SIRO). This acknowledgment not only validates SKAN's innovative medical approaches but also reinforces its status as one of the fastest-growing medical research organizations in the region.

Recognition Under Section 35(1) of the Income-tax Act

The Ministry of Finance has officially approved SKAN for a period of five years under the category of 'Research Association for Scientific Research', in accordance with Section 35(1)(ii) of the Income-tax Act. This approval came after an extensive evaluation by the Central Board of Direct Taxes, which scrutinized various aspects of SKAN’s operations, including its scientific outputs, laboratory practices, and innovative research initiatives. The tax benefits associated with this recognition are expected to significantly enhance donations and funding for SKAN's scientific endeavors.

Impact of the Approval on Research Funding

The approval under Section 35(1)(ii) will facilitate increased monetary support, enabling SKAN to elevate its research capabilities. This financial backing will open new avenues for groundbreaking studies, particularly in the areas of artificial intelligence applications in healthcare, bioinformatics, and other crucial health-related projects.

SIRO Designation: A Milestone Achievement

In addition to the Research Association recognition, the Department of Scientific and Industrial Research has acknowledged SKAN as a Scientific and Industrial Research Organization (SIRO). This recognition is a testament to the innovative contributions by SKAN scientists, who have published multiple patents and research papers in a variety of pivotal medical fields. The SIRO status not only boosts SKAN’s credibility but also provides several operational advantages, including customs duty exemptions on research equipment purchases.

Enhancing Research Capabilities

The SIRO designation serves as a significant milestone that will propel SKAN into a new phase of research development. With this recognition, the organization is better positioned to embark on extensive research projects, focusing on long-term solutions for chronic health conditions.

Leadership Insights on Achievements

Ashok Soota, the Chairman & Managing Trustee of SKAN, expressed his enthusiasm regarding these significant recognitions. He noted, "These various approvals have come in a short span since SKAN commenced operations. The recognition will establish SKAN's reputation as a prestigious medical research institution and enable us to plan our growth with confidence." His perspective underscores the importance of these recognitions in shaping the future ambitions of SKAN.

Furthermore, Dr. Yogesh Shouche, the Director of SKAN, affirmatively stated, "The SIRO recognition is an important milestone for SKAN. This will enable SKAN to develop major research programs and encourage our researchers to plan for mid and long term projects." These statements reveal the optimism and forward-thinking approach within the organization.

About SKAN Research Trust

Based in Bengaluru, SKAN Research Trust is a not-for-profit medical research entity that leverages transformational technologies to develop innovative therapies aimed at addressing issues such as aging, cardiovascular diseases, diabetes, and lifestyle-related disorders. The organization taps into a wide range of expertise, including genomics, stem cells, and molecular biology, to create gentler treatment protocols that are more effective and less invasive. Their mission is clear: to "Transform the future of medicine. Impacting millions of lives."

Frequently Asked Questions

What is SKAN Research Trust?

SKAN Research Trust is a not-for-profit organization focused on advancing medical research, particularly in developing therapies for various health issues.

What recognitions has SKAN recently received?

SKAN has gained recognitions as a Research Association for Scientific Research and as a Scientific and Industrial Research Organization (SIRO) by the Government of India.

How does the SIRO designation benefit SKAN?

The SIRO designation provides SKAN with customs duty exemptions on research-related equipment and boosts its credibility in the scientific community.

What are the future plans for SKAN Research Trust?

SKAN plans to embark on extensive research programs that leverage the recent government approvals to develop long-term health solutions.

Who leads SKAN Research Trust?

Mr. Ashok Soota is the Chairman & Managing Trustee, guiding SKAN's vision and strategic initiatives in medical research.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

Endeavour Mining Sees Significant Stake Notification from BlackRock

Updated Category News Views 141

Endeavour Mining and Major Shareholding Update Endeavour Mining plc is making headlines with its latest update regarding shareholders. Recently, the company received a notable notification from BlackRock, Inc., one of the world’s leading investment management firms. This announcement highlights BlackRock's interests in Endeavour Mining, showcasing the ongoing...

Continue Reading
Concerns Rise as Collaborative Leaders Depart Congress Rapidly

Updated Category News Views 48

New Findings on Congressional Collaboration Recently, an insightful report emerged emphasizing the ongoing shifts within Congress, revealing a notable trend that could hinder bipartisan efforts. The analysis underscores the departures of many collaborative members, dubbed 'bridgers', poised to leave their positions, thus raising alarms about the future of political...

Continue Reading
Latest Safety Recalls: Critical Updates on Consumer Products

Updated Category News Views 271

Consumer product recalls can ripple through markets faster than a bad earnings report. Back in mid-2024, we saw some significant shake-ups with companies like John Deere and Liberty Hardware facing public scrutiny over safety issues. For traders, these incidents aren’t just corporate headaches; they’re potential red flags on the balance sheets that could send stock...

Continue Reading
Investors Unite: ASP Isotopes Inc. Faces Major Legal Challenge

Updated Category News Views 118

Understanding the Legal Challenge Against ASP Isotopes Inc. The Schall Law Firm, recognized for its commitment to investor rights, has brought significant attention to a recent class action lawsuit involving ASP Isotopes Inc. (NASDAQ: ASPI). This lawsuit addresses serious allegations regarding the company's transparency and accuracy in reporting its technological...

Continue Reading
Elyce Arons: Keynote Speaker and Honorary Doctorate Recipient

Updated Category News Views 101

Elyce Arons to Speak at LIM College Commencement Elyce Arons, the Founder and CEO of Frances Valentine, is set to take the stage as the keynote speaker at the upcoming commencement ceremony for the Class of 2026 at LIM College. This prestigious event will highlight her journey and accomplishments within the fashion industry, inspiring graduates to chase their dreams....

Continue Reading